For years, conversations about dementia prevention have focused largely on lifestyle. Regular exercise, nutritious eating, quality sleep, cognitive stimulation, and managing cardiovascular risk factors have consistently been linked to better brain health.
More recently, another topic has entered the conversation: GLP-1 medications.
Originally developed to help manage type 2 diabetes—and now widely used for obesity treatment—these medications have attracted growing scientific interest for their potential effects beyond blood sugar and weight management. Researchers are now asking an important question:
Could combining evidence-based lifestyle coaching with metabolism-targeting medications provide greater protection for brain health than either approach alone?
While no one has the answer yet, one of the biggest announcements at the 2026 Alzheimer’s Association International Conference (AAIC) signals where dementia prevention research may be headed next.
Introducing PROTECT-Cog
Researchers announced the launch of PROTECT-Cog (Prevention of Risk for Cognitive Decline Through Combined Therapy)—a major international research initiative expected to invest approximately $100 million into studying strategies to reduce the risk of cognitive decline.
Unlike previous studies, PROTECT-Cog won’t look at lifestyle interventions or medication in isolation. Instead, researchers plan to investigate whether combining both approaches can produce greater benefits for brain health.
Participants will be followed for three years, allowing researchers to evaluate long-term changes in cognition, physical function, quality of life, and overall health.
Importantly, this is a study announcement—not a completed clinical trial. Recruitment and follow-up are planned, but no results have been published yet.
What Will Researchers Study?
The planned study will compare different approaches to supporting healthy aging.
Participants are expected to receive:
A structured multidomain lifestyle intervention
A less intensive (“structured-lite”) lifestyle program for comparison
A metabolism-targeting medication, potentially a GLP-1 receptor agonist, where appropriate
Researchers will evaluate several important outcomes, including:
Cognitive function
Frailty
Quality of life
Overall health
Rather than asking whether one solution is better than another, PROTECT-Cog reflects a broader shift toward understanding how multiple interventions may work together to support healthy aging.
Why Are GLP-1 Medications Receiving Attention?
GLP-1 receptor agonists have transformed the treatment of type 2 diabetes and obesity by helping regulate blood sugar, appetite, and body weight.
Because metabolic health and brain health are closely connected, researchers have become increasingly interested in whether improving glucose regulation, reducing inflammation, and supporting cardiovascular health could also influence cognitive aging.
Several observational studies have suggested that people taking GLP-1 medications may experience lower rates of dementia than similar individuals who are not taking these medications.
These findings are promising—but they are not proof that GLP-1 medications prevent dementia.
Observational studies can identify associations, but they cannot establish cause and effect.
That’s exactly why randomized clinical trials like PROTECT-Cog are so important.
Lifestyle Still Matters
One of the most encouraging aspects of PROTECT-Cog is that lifestyle remains at the center of the research.
Rather than viewing medication as a replacement for healthy habits, researchers are investigating whether medical treatment and lifestyle coaching may complement one another.
The structured lifestyle program includes many of the same evidence-based strategies that continue to appear throughout healthy aging research:
- Regular physical activity
- Healthy nutrition
- Cognitive engagement
- Social connection
- Cardiometabolic health management
- Ongoing coaching and accountability
This reflects a growing understanding that healthy aging rarely depends on one intervention alone.
Instead, long-term health is influenced by multiple factors working together.
What This Means for PrimeSpan
The announcement of PROTECT-Cog reinforces an important direction in healthy longevity research.
Increasingly, scientists are moving beyond the question of whether lifestyle or medication works best.
Instead, they’re asking how different evidence-based approaches can be combined to help people age healthier for longer.
At PrimeSpan, we’ve long believed that lasting behavior change requires more than information alone. It requires practical action plans, ongoing support, accountability, and habits that can be sustained over time.
While medications may become an important tool for some individuals under the guidance of their healthcare provider, they should be viewed as one part of a comprehensive healthy aging strategy—not a substitute for movement, nutrition, strength, sleep, cognitive engagement, and social connection.
What This Research Doesn’t Tell Us—Yet
Because PROTECT-Cog has only been announced, it’s important to be clear about what we don’t know.
The study has not shown that GLP-1 medications prevent dementia.
It has not demonstrated that combining medication with lifestyle coaching is more effective than lifestyle intervention alone.
And it has not established that these medications should be used specifically for dementia prevention.
Those questions are exactly what researchers hope to answer over the coming years.
Until then, the strongest evidence for supporting long-term brain health continues to include regular physical activity, balanced nutrition, cardiovascular risk management, quality sleep, cognitive stimulation, and meaningful social engagement.
Looking Ahead
Healthy aging research is entering an exciting new chapter.
As scientists continue exploring how medical treatments and lifestyle interventions may complement one another, one principle remains remarkably consistent:
Healthy habits continue to provide the foundation for lifelong well-being.
Whether future research confirms additional benefits from metabolism-targeting medications or not, the everyday choices we make—moving more, eating well, staying mentally active, managing chronic conditions, and remaining socially connected—will continue to play an essential role in supporting healthy aging.
At PrimeSpan, we’ll continue following emerging research while staying grounded in evidence, helping adults over 55 make informed decisions that support their health today and in the years ahead.
